Simergent is Reinventing the PD Cycler
Founded in 2014, the small Chicago start-up is using $2.8M in venture capital to develop a cheaper, simpler PD cycler with a color touchscreen, silent operation, and a device to help prevent peritonitis.
Read the full article » | Posted 05-15-2019
Related Articles
- Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
- FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
- Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
- Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026